Literature DB >> 30036705

Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery.

Michael Kriss1, Keith Z Hazleton2, Nichole M Nusbacher3, Casey G Martin4, Catherine A Lozupone5.   

Abstract

Dysbiosis, an imbalance in microbial communities, is linked with disease when this imbalance disturbs microbiota functions essential for maintaining health or introduces processes that promote disease. Dysbiosis in disease is predicted when microbiota differ compositionally from a healthy control population, but only truly defined when these differences are mechanistically related to adverse phenotypes. For the human gut microbiota, dysbiosis varies across diseases. One common manifestation is replacement of the complex community of anaerobes typical of the healthy adult gut microbiome with a community of lower overall microbial diversity and increased facultative anaerobes. Here we review diseases in which low-diversity dysbiosis has been observed and mechanistically linked with disease, with a particular focus on liver disease, inflammatory bowel disease, and Clostridium difficile infection.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30036705      PMCID: PMC6435260          DOI: 10.1016/j.mib.2018.07.003

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  58 in total

1.  Environmental factors in inflammatory bowel disease: a co-twin control study of a Swedish-Danish twin population.

Authors:  Jonas Halfvarson; Tine Jess; Anders Magnuson; Scott M Montgomery; Marianne Orholm; Curt Tysk; Vibeke Binder; Gunnar Järnerot
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

Review 2.  Host-bacterial mutualism in the human intestine.

Authors:  Fredrik Bäckhed; Ruth E Ley; Justin L Sonnenburg; Daniel A Peterson; Jeffrey I Gordon
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

3.  Molecular analysis of the gut microbiota of identical twins with Crohn's disease.

Authors:  Johan Dicksved; Jonas Halfvarson; Magnus Rosenquist; Gunnar Järnerot; Curt Tysk; Juha Apajalahti; Lars Engstrand; Janet K Jansson
Journal:  ISME J       Date:  2008-04-10       Impact factor: 10.302

4.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Host and pathogen factors for Clostridium difficile infection and colonization.

Authors:  Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; François Lamothe; Sophie Michaud; Nathalie Turgeon; Baldwin Toye; Axelle Beaudoin; Eric H Frost; Rodica Gilca; Paul Brassard; Nandini Dendukuri; Claire Béliveau; Matthew Oughton; Ivan Brukner; Andre Dascal
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

6.  Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients.

Authors:  J E Wells; F Berr; L A Thomas; R H Dowling; P B Hylemon
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

7.  Bile salts and glycine as cogerminants for Clostridium difficile spores.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2008-02-01       Impact factor: 3.490

8.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.

Authors:  J Hampe; A Cuthbert; P J Croucher; M M Mirza; S Mascheretti; S Fisher; H Frenzel; K King; A Hasselmeyer; A J MacPherson; S Bridger; S van Deventer; A Forbes; S Nikolaus; J E Lennard-Jones; U R Foelsch; M Krawczak; C Lewis; S Schreiber; C G Mathew
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

9.  Identifying genomic and metabolic features that can underlie early successional and opportunistic lifestyles of human gut symbionts.

Authors:  Catherine Lozupone; Karoline Faust; Jeroen Raes; Jeremiah J Faith; Daniel N Frank; Jesse Zaneveld; Jeffrey I Gordon; Rob Knight
Journal:  Genome Res       Date:  2012-06-04       Impact factor: 9.043

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  79 in total

Review 1.  Functional Microbiomics in Liver Transplantation: Identifying Novel Targets for Improving Allograft Outcomes.

Authors:  Michael Kriss; Elizabeth C Verna; Hugo R Rosen; Catherine A Lozupone
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

2.  Arthropod-bacteria interactions influence assembly of aquatic host microbiome and pathogen defense.

Authors:  Sasha E Greenspan; Mariana L Lyra; Gustavo H Migliorini; Mônica F Kersch-Becker; Molly C Bletz; Cybele Sabino Lisboa; Mariana R Pontes; Luisa P Ribeiro; Wesley J Neely; Felipe Rezende; Gustavo Q Romero; Douglas C Woodhams; Célio F B Haddad; Luís Felipe Toledo; C Guilherme Becker
Journal:  Proc Biol Sci       Date:  2019-06-26       Impact factor: 5.349

3.  Probiotics maintain the intestinal microbiome homeostasis of the sailors during a long sea voyage.

Authors:  Jiachao Zhang; Jinshan Zhao; Hao Jin; Ruirui Lv; Huiwen Shi; Guozhong De; Bo Yang; Zhihong Sun; Heping Zhang
Journal:  Gut Microbes       Date:  2020-02-20

Review 4.  Gut Microbiota in Patients with Morbid Obesity Before and After Bariatric Surgery: a Ten-Year Review Study (2009-2019).

Authors:  Spyridon G Koulas; Christos K Stefanou; Stefanos K Stefanou; Kostas Tepelenis; Nikolaos Zikos; Konstantinos Tepetes; Andreas Kapsoritakis
Journal:  Obes Surg       Date:  2020-11-01       Impact factor: 4.129

Review 5.  Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia.

Authors:  Michael W Gleeson
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

6.  Probiotics Modulate a Novel Amphibian Skin Defense Peptide That Is Antifungal and Facilitates Growth of Antifungal Bacteria.

Authors:  Douglas C Woodhams; Louise A Rollins-Smith; Laura K Reinert; Briana A Lam; Reid N Harris; Cheryl J Briggs; Vance T Vredenburg; Bhumi T Patel; Richard M Caprioli; Pierre Chaurand; Peter Hunziker; Laurent Bigler
Journal:  Microb Ecol       Date:  2019-05-16       Impact factor: 4.552

7.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

8.  Self-reported sleep quality is associated with gut microbiome composition in young, healthy individuals: a pilot study.

Authors:  Gregory J Grosicki; Bryan L Riemann; Andrew A Flatt; Taylor Valentino; Michael S Lustgarten
Journal:  Sleep Med       Date:  2020-04-23       Impact factor: 3.492

9.  Early life stress in mice alters gut microbiota independent of maternal microbiota inheritance.

Authors:  Keri M Kemp; Jackson Colson; Robin G Lorenz; Craig L Maynard; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-03-03       Impact factor: 3.619

10.  Dietary switch to Western diet induces hypothalamic adaptation associated with gut microbiota dysbiosis in rats.

Authors:  Véronique Douard; Gaëlle Boudry; Mélanie Fouesnard; Johanna Zoppi; Mélanie Petera; Léa Le Gleau; Carole Migné; Fabienne Devime; Stéphanie Durand; Alexandre Benani; Samuel Chaffron
Journal:  Int J Obes (Lond)       Date:  2021-03-13       Impact factor: 5.095

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.